Physician profile
Donald R Ward
NPI 1316916869
$1,642.09
in general payments reported to CMS, 2019-2025
9 companies · $325 in 2025
The $325 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.04 · 2020: $40.91 · 2021: $60.38 · 2022: $27.05 · 2023: $954 · 2024: $170 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653 · Travel and Lodging: $597 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.92 |
| Travel and Lodging | $597.25 |
| Education | $198.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,396.74 | 2019-2025 | Comprehensive Shoulder System, Persona, Anterior Supine Stem Extractor |
| Stryker Corporation | $60.38 | 2021 | |
| United Imaging Healthcare North America LLC | $41.98 | 2019 | |
| Ethicon US, LLC | $36.29 | 2025 | Vistaseal |
| Alon Medical Technology | $33.13 | 2024 | |
| Heron Therapeutics, INC. | $19.62 | 2025 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $18.75 | 2025 | |
| Medela LLC | $17.71 | 2024 | Invia Motion Endure |
| Catalyst Orthoscience | $17.49 | 2024 | Catalyst Csr Shoulder System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.